Navigation Links
Cedars-Sinai study examines regional use of minimally invasive repair of aneurysms
Date:4/2/2010

LOS ANGELES (April 1, 2010) While health policy researchers commonly suggest that geographic variations in the amount of medical care provided can be attributed to hospital costs or physician practice patterns, a new study examining regional utilization of a specific surgical procedure minimally invasive aneurysm repair shows that is not the case.

Researchers at Cedars-Sinai Medical Center in Los Angeles have found that the utilization of endovascular aortic abdominal aneurysm repair was not associated with physician capacity and distribution, socioeconomics or other non-medical factors, but rather with a patient's cardiovascular risk factors, disease prevalence and the clinical judgment of physicians.

Details of this study were reported in the April issue of the Journal of Vascular Surgery.

Endovascular aortic abdominal aneurysm repair is a procedure to repair a ballooning of the aorta, and is similar to the stent placement in a coronary artery after angioplasty. While the total number of aneurysms found in the population has remained about the same over the last several decades, the number of aortic aneurysm repairs performed as open surgeries has decreased by 48 percent, while the number of aneurysms repaired endovascularly increased by more than 100 percent since the procedure was introduced in the 1990s.

"Until now, little has been known about what medical and non-medical factors influence the use of minimally invasive vascular surgical repair," said Bruce Gewertz, MD, chair of the department of surgery at Cedars-Sinai Medical Center and the study's principal investigator. "But because vascular surgeons perform both open and minimally invasive aneurysm repair, the data on decision-making aspects of the patients' medical care could be analyzed in a more straight forward manner."

"In the study, we found that increased use of the endovascular procedure to repair an aortic abdominal aneurysm correlated most closely with higher-risk patient populations and with physicians who were more experienced in treating aneurysms," said Gewertz, who is also surgeon-in-chief and the Harriet and Steven Nichols Endowed Chair in Surgery at Cedars-Sinai Medical Center "Contrary to some conventional thinking, use was not strongly influenced by many of the economic factors previously thought to be predictive."

Researchers examined the use of endovascular aortic abdominal aneurysm repair from 2001 to 2006 across 29 states to test the hypothesis that the utilization of innovative vascular procedures by vascular surgeons more closely reflects disease prevalence and consistent clinical judgment than non-medical considerations. The utilization rates varied widely between states, from 39.3 percent to 69.9 percent; use of the procedure was highest in states with higher incidences of aneurysms and a greater number of deaths from heart disease.

A previous investigation by the research team showed that variations in the rates of carotid endarterectomy actually reflected regional risk factors for atherosclerosis not physician density of other socioeconomic drivers.

"By documenting disparities and variations in care, this study and others like them can help define best practice treatment pathways and may lead to new ways to examine inequalities in preventive diagnostic and therapeutic inefficiencies at the systems level," said Gewertz.


'/>"/>

Contact: Simi Singer
simi.singer@cshs.org
310-423-7798
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. Research team led by Cedars-Sinai identifies genes linked to ulcerative colitis
2. Cedars-Sinai Heart Institute physicians present findings at ACC scientific meeting
3. Casual Sex Doesnt Cause Emotional Damage: Study
4. Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
5. Screening for Spinal Muscular Atrophy Not Cost-Effective: Study
6. New study finds possible source of beta cell destruction that leads to Type 1 diabetes
7. New Study Demonstrates Novel Use of Metabolic Imaging to Locate Sperm in Infertile Men -- Non-Invasive Imaging Procedure May Replace Invasive Techniques such as Testicula
8. Risk of stroke lower for recent Ontario immigrants: study
9. Definitive study confirms chemo benefit in postmenopausal breast cancer
10. Experimental stem cell treatment arrests acute lung injury in mice, study shows
11. Violence is part of the job say nurses as study shows only 1 in 6 incidents are reported
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... National recruitment ... a life sciences executive with extensive sequencing and genomics experience, as Vice President of ... position, Ms. Hill will be responsible for leading the sales team in the commercialization ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... pluripotent stem (iPS) cells and other difficult to transfect cells, announces its launch ... PluriQ™ G9™ Gene Editing System is a complete system for culturing ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: